These findings clearly demonstrate that the EVOO polyphenol oleuropein aglycone depletes HER2 receptor from cell-surface in breast cancer cells naturally exhibiting HER2 gene amplification and HER2 protein overexpression (i.e., SKBR3 cells). The gene discussed is ERBB2; the disease is breast carcinoma.